한국형 우울장애 약물치료 알고리듬 2021 (IV): 여성 및 노인
Korean Medication Algorithm Project for Depressive Disorder 2021 (IV): Female and Elderly
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives An expert consensus guideline for the treatment of depressive disorder, the Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD), was first established in 2002 and updated in 2017. To provide an up-to-date treatment guideline, KMAP-DD 2021 was recently completed. This study was undertaken to provide a guideline for the treatment of depressive disorder in a selected population that included females and elderly. Methods The survey conducted consisted of 7 questionnaires for each population, females and elderly, with depressive disorder. A total of 65 of 97 experienced psychiatrists answered the survey. Results For the treatment of premenstrual dysphoric disorder, the selective serotonin reuptake inhibitors, venlafaxine, and desvenlafaxine were recommended as first-line therapies. For major depressive disorder (MDD) during pregnancy, antidepressant (AD) monotherapy was recommended as a first-line therapy for mild to moderate and severe depression, and combined electroconvulsive therapy and AD with atypical antipsychotics (AAP) were recommended as a first-line therapy for severe depression with psychotic features. AD plus AAP was generally recommended for post-partum depression. In elderly with depression, AD monotherapy was recommended as the treatment of choice for mild to moderate episodes, and AD monotherapy and AD plus AAP were recommended as a first-line therapy for severe depression without psychotic features. Lastly, AD plus AAP was chosen as the treatment of choice for psychotic depression. Conclusion Present study provides an updated algorithm for the treatment of females and elderly with depressive disorders. This algorithm provides a practical aid to clinicians for the treatment of females and elderly with MDD.
Abstract
Objectives An expert consensus guideline for the treatment of depressive disorder, the Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD), was first established in 2002 and updated in 2017. To provide an up-to-date treatment guideline, KMAP-DD 2021 was recently completed. This study was undertaken to provide a guideline for the treatment of depressive disorder in a selected population that included females and elderly. Methods The survey conducted consisted of 7 questionnaires for each population, females and elderly, with depressive disorder. A total of 65 of 97 experienced psychiatrists answered the survey. Results For the treatment of premenstrual dysphoric disorder, the selective serotonin reuptake inhibitors, venlafaxine, and desvenlafaxine were recommended as first-line therapies. For major depressive disorder (MDD) during pregnancy, antidepressant (AD) monotherapy was recommended as a first-line therapy for mild to moderate and severe depression, and combined electroconvulsive therapy and AD with atypical antipsychotics (AAP) were recommended as a first-line therapy for severe depression with psychotic features. AD plus AAP was generally recommended for post-partum depression. In elderly with depression, AD monotherapy was recommended as the treatment of choice for mild to moderate episodes, and AD monotherapy and AD plus AAP were recommended as a first-line therapy for severe depression without psychotic features. Lastly, AD plus AAP was chosen as the treatment of choice for psychotic depression. Conclusion Present study provides an updated algorithm for the treatment of females and elderly with depressive disorders. This algorithm provides a practical aid to clinicians for the treatment of females and elderly with MDD.
참고문헌 (33)
- Hyler SE, "APA online CME practice guideline for the treatment of patients with major depressive disorder", J Psychiatr Pract, 8, pp.315~319 (2002)
- Patten SB, "Updated CANMAT guidelines for treatment of major depressive disorder", Can J Psychiatry, 61, pp.504~505 (2016)
- Davidson JR, "Major depressive disorder treatment guidelines in America and Europe", J Clin Psychiatry, 71(Suppl E1), pp.e04~ (2010)
- Kirmayer LJ, "Cultural variations in the clinical presentation of depression and anxiety: implications for diagnosis and treatment", J Clin Psychiatry, 62(Suppl 13), pp.22~28 (2001)
- Lee MS, "The Korean Medication Algorithm for Major Depressive Disorder (KMAMDD):report of the Korean Society of Depressive and Bipolar Disorders", Int J Psychiatry Clin Pract, 10, pp.186~194 (2006)
- 서정석, "한국형 우울장애 약물치료 알고리듬 2006 (Ⅰ)", 신경정신의학, 46(5), pp.453~460 (2007), 대한신경정신의학회
- Seo JS, "The Korean Medication Algorithm for Depressive Disorder: second revision", J Affect Disord, 167, pp.312~321 (2014)
- Jeong Seok Seo, "Korean Medication Algorithm for Depressive Disorders 2017: Third Revision", Clinical Psychopharmacology and Neuroscience, 16(1), pp.67~87 (2018), 대한정신약물학회[DOI]
- "Number of depression in females exceeded 450,000 in year 2017, twice higher than in males" (2018)[URL]
- "Eldery suffers from mental healthy, 4 out of 10 depressied people were people older than 60"[URL]
- Park JH, "Prevalence of major depressive disorder and minor depressive disorder in an elderly Korean population : results from the Korean Longitudinal Study on Health and Aging(KLoSHA)", J Affect Disord, 125, pp.234~240 (2010)
- Aoyama H, "Environmental problems and public health nursing. (5). Chemical substances and health. 2", Hokenfu Zasshi, 32, pp.336~348 (1976)
- Young-Eun Jung, "Validation of the Korean Version of the Depression in Old Age Scale and Comparison with Other Depression Screening Questionnaires Used in Elderly Patients in Medical Settings", Clinical Psychopharmacology and Neuroscience, 17(3), pp.369~376 (2019), 대한정신약물학회[DOI]
- Sassarini DJ, "Depression in midlife women", Maturitas, 94, pp.149~154 (2016)
- O’Connor E, "Primary care screening for and treatment of depression in pregnant and postpartum women : evidence report and systematic review for the US Preventive Services Task Force", JAMA, 315, pp.388~406 (2016)
- Kok RM, "Management of depression in older adults: a review", JAMA, 317, pp.2114~2122 (2017)
- Carlini SV, "Evidence-based treatment of premenstrual dysphoric disorder : a concise review", J Clin Psychiatry, 81 (2020)
- Sachs GS, "The expert consensus guideline series : medication treatment of bipolar disorder 2000", Postgrad Med, pp.1~104 (2000)
- Hofmeister S, "Premenstrual syndrome and premenstrual dysphoric disorder", Am Fam Physician, 94, pp.236~240 (2016)
- Lanza di Scalea T, "Premenstrual dysphoric disorder", Med Clin North Am, 103, pp.613~628 (2019)
- Sansone RA, "Serotonin norepinephrine reuptake inhibitors : a pharmacological comparison", Innov Clin Neurosci, 11, pp.37~42 (2014)
- Fischer Fumeaux CJ, "Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence - an update", Expert Opin Drug Saf, 18, pp.949~963 (2019)
- Vivenzio V, "Depression in pregnancy : focus on the safety of antidepressant drugs", Recenti Prog Med, 109, pp.432~442 (2018)
- Rodriguez-Cabezas L, "Psychiatric emergencies in pregnancy and postpartum", Clin Obstet Gynecol, 61, pp.615~627 (2018)
- Ward HB, "Recommendations for the use of ECT in pregnancy : literature review and proposed clinical protocol", Arch Womens Ment Health, 21, pp.715~722 (2018)
- MacQueen GM, "Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 6. Special populations: youth, women, and the elderly", Can J Psychiatry, 61, pp.588~603 (2016)
- Tebeka S, "Clinical characteristics of bipolar disorders with postpartum depressive onset", Prog Neuropsychopharmacol Biol Psychiatry, 107, pp.110225~ (2021)
- Changsu Han, "The Potential Utility of Aripiprazole Augmentation for Major Depressive Disorder with Mixed Features Specifier: A Retrospective Study", Clinical Psychopharmacology and Neuroscience, 17(4), pp.495~502 (2019), 대한정신약물학회[DOI]
- Wright BM, "Augmentation with atypical antipsychotics for depression: a review of evidence-based support from the medical literature", Pharmacotherapy, 33, pp.344~359 (2013)
- Gressier F, "Postpartum electroconvulsive therapy : a systematic review and case report", Gen Hosp Psychiatry, 37, pp.310~314 (2015)
- Lavretsky H, "Citalopram, methylphenidate, or their combination in geriatric depression:a randomized, double-blind, placebo-controlled trial", Am J Psychiatry, 172, pp.561~569 (2015)
- Lenze EJ, "Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial", Lancet, 386, pp.2404~2412 (2015)
- Cakir S, "Atypical antipsychotics as add-on treatment in late-life depression", Clin Interv Aging, 11, pp.1193~1198 (2016)